Status:
UNKNOWN
The Effect of Chemotherapy on Regulatory T Cells
Lead Sponsor:
Ankara Children's Health and Diseases Hematology and Oncology Training and Research Hospital
Collaborating Sponsors:
Turkish Society of Hematology
Conditions:
Pre B ALL
Regulatory T Cell
Eligibility:
All Genders
1-18 years
Brief Summary
The investigators aimed to study the effect of chemotherapy on regulatory T cells (Tregs) in children with precursor B (PreB) acute lymphoblastic leukemia (ALL) at 15 and 33 days of malignity directed...
Eligibility Criteria
Inclusion
- Children between 1-18 years
- Recent PreB ALL diagnosis
Exclusion
- Children under 1 or over 18 years
- Underlying disease e.g. immune deficiency, germline mutations or diseases
- Tcell ALL or acute myeloid leukemia (AML) patients
Key Trial Info
Start Date :
January 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03413046
Start Date
January 1 2018
End Date
May 1 2019
Last Update
January 29 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.